We are live on ! Find out more
ECYT

Endocyte, Inc. Common Stock
ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

Back to rankings

Fund managers haven’t disclosed any holdings of ECYT yet.

ECYT Hedge Fund Activity: Q1 2019 in Review

0 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q1 2019, worth a combined $0 — down 100% from $1.45M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ECYT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Claro Advisors, exiting entirely with an estimated $9K sold.

  • 0 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q1 2019, down from 2 in Q4 2018.
  • Funds reported $0 of Endocyte, Inc. Common Stock stock for Q1 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Endocyte, Inc. Common Stock positions in Q1 2019 and 1 closed out, a net change of -1 holder.
  • The largest Endocyte, Inc. Common Stock seller in Q1 2019 was Claro Advisors, an estimated $9K sold.

Based on aggregated 13F filings for Q1 2019.